We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.63B
AUM Growth
+$207M
Cap. Flow
+$60.4M
Cap. Flow %
2.3%
Top 10 Hldgs %
28.14%
Holding
809
New
149
Increased
180
Reduced
264
Closed
108
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNW icon
676
Genworth Financial
GNW
$3.8B
$126K ﹤0.01%
23,900
YEXT icon
677
Yext
YEXT
$493M
$126K ﹤0.01%
+19,290
New +$105K
NETI
678
DELISTED
Eneti Inc.
NETI
$119K ﹤0.01%
+11,858
New +$105K
BHR
679
Braemar Hotels & Resorts
BHR
$148M
$116K ﹤0.01%
28,215
-21,000
-43% -$86.2K
VRN
680
DELISTED
Veren
VRN
$111K ﹤0.01%
15,557
-17,443
-53% -$129K
PCTI
681
DELISTED
PCTEL, Inc. Common Stock
PCTI
$94.8K ﹤0.01%
22,047
-9,500
-30% -$42.4K
UNIT
682
Uniti Group
UNIT
$2.68B
$94K ﹤0.01%
17,007
-56,564
-77% -$388K
SUP
683
DELISTED
Superior Industries International
SUP
$93.9K ﹤0.01%
+22,249
New +$94.4K
VISN
684
Vistance Networks Inc
VISN
$2.69B
$93.3K ﹤0.01%
12,700
-32,500
-72% -$314K
NHS
685
Neuberger High Yield Strategies Fund Inc
NHS
$251M
$92.3K ﹤0.01%
10,839
CRBU icon
686
Caribou Biosciences
CRBU
$162M
$89.3K ﹤0.01%
14,216
-5,484
-28% -$48.8K
OPTT icon
687
Ocean Power Technologies
OPTT
$46.9M
$73.7K ﹤0.01%
+163,754
New +$112K
ESOA icon
688
Energy Services of America
ESOA
$312M
$65.5K ﹤0.01%
25,300
+2,000
+9% +$5.5K
CLSD
689
DELISTED
Clearside Biomedical
CLSD
$53.5K ﹤0.01%
+3,187
New +$57.4K
LENZ
690
LENZ Therapeutics
LENZ
$158M
$52.7K ﹤0.01%
2,267
-2,204
-49% -$51.1K
ARC
691
DELISTED
ARC Document Solutions, Inc.
ARC
$50.7K ﹤0.01%
+17,300
New +$45.8K
GEVO icon
692
Gevo
GEVO
$445M
$50K ﹤0.01%
+26,300
New +$55.5K
EVLV icon
693
Evolv Technologies
EVLV
$948M
$48.7K ﹤0.01%
+18,800
New +$55.3K
UBX
694
DELISTED
Unity Biotechnology
UBX
$48.5K ﹤0.01%
17,700
+12,600
+247% +$36.6K
IONQ icon
695
IonQ
IONQ
$12.7B
$43.5K ﹤0.01%
+12,600
New +$60.8K
AKLI
696
DELISTED
Akili Inc
AKLI
$43K ﹤0.01%
38,357
SAN icon
697
Banco Santander
SAN
$189B
$42.4K ﹤0.01%
14,362
TRVI icon
698
Trevi Therapeutics
TRVI
$2.44B
$40.9K ﹤0.01%
+21,200
New +$41.8K
LPCN icon
699
Lipocine
LPCN
$18.1M
$31.9K ﹤0.01%
+4,880
New +$35.6K
OVID icon
700
Ovid Therapeutics
OVID
$448M
$23.4K ﹤0.01%
12,600
+800
+7% +$1.36K

Similar funds

Bailard's Q4 2022 Portfolio in Review

As of Q4 2022, Bailard held 809 positions worth $2.63B, up 8.6% from $2.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bailard's Q4 2022 filing shows 149 new, 180 increased, 264 reduced and 108 closed positions. Its largest new stake was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF: 92,930 shares worth $3.16M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $135M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q4 2022 buy was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF: 92,930 shares worth $3.16M.
  • Bailard added most to State Street SPDR Nuveen ICE Municipal Bond ETF in Q4 2022, an estimated $78.7M increase.
  • Bailard's biggest Q4 2022 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $135M.
  • Bailard fully exited FedEx in Q4 2022, selling an estimated $2.24M.
  • Bailard's ten largest holdings make up 28% of its $2.63B portfolio in Q4 2022.
  • Bailard opened 149 new positions and closed 108 in Q4 2022.
  • Bailard's portfolio value rose 8.6% quarter-over-quarter to $2.63B.

Based on Bailard's 13F filing for Q4 2022, filed 2 Feb 2023.